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A B S T R A C T   
Background: Prevalence studies among prisoners have found rates of 1–4% for autism spectrum 
disorder (ASD) or autistic traits. However, little is known about those prisoners with high levels of 
autistic traits. 
Aim: This aim of this study was to compare the mental health characteristics of prisoners with 
autistic traits with neurotypical prisoners not screening positive for neurodevelopmental 
disorders. 
Method: The study recruited 240 male prisoners from a London prison and screened for autism 
spectrum disorder using the Autism Quotient (AQ) 20 and 10, and Autism Diagnostic Observation 
Schedule (ADOS). The Mini International Neuropsychiatric Interview was used to assess for 
depression, anxiety, self-harm behavior and suicide. 
Results: Screening using the AQ identified 46 prisoners with significant autistic traits, with 12 
meeting the diagnostic threshold for ASD using the ADOS. Those screening positive with autistic 
traits were significantly more likely to have thought about self-harm and suicide in the past 
month than neurotypical prisoners and have a comorbid mental disorder. They were also 
significantly more likely to report having attempted suicide during their lifetime compared to 
neurotypical peers at a rate of 64.9 % compared to 11.6 % for the neurotypical prisoners. 
Conclusion: Prisoners with elevated levels of autistic traits were more likely to report self-harm, 
suicidal thoughts and were more vulnerable to a range of mental disorders than neurotypical 
prisoners. There is a need for more evidence on the experience of autistic prisoners to inform how 
pathways should work to improve health outcomes through increased awareness and access to 
screening and subsequent diagnosis which currently prisons are currently not set up for.   
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What this paper adds? 
The elevated presence of autistic traits and neurodevelopmental impairments are not often considered when screening and 
assessing prisoners as part of the routine health screening. The presence of elevated levels of autistic traits has been put forward as a 
risk factor for psychiatric disorder. This paper increases our knowledge of prisoners with elevated autistic traits who reported higher 
levels of mental illness and thoughts of self-harm and suicidal ideation compared to neurotypical prisoners. This study has shown there 
is a need to consider this group given the elevated clinical need, relating to mental health and risk to self, by improving identification 
and awareness within custodial settings 
1. Introduction 
Autism spectrum disorder (ASD) is an early onset, pervasive and lifelong neurodevelopmental disorder. It is characterized by 
impairments in social communication and repetitive, restricted behaviour patterns and atypical response to sensory stimuli (American 
Psychiatric Association, 2013). There is significant variation in the course and presentation of ASD depending on multiple factors for 
example severity of core and secondary symptoms, the level of intellectual ability and adaptive functioning possessed by the (Ronald & 
Hoekstra, 2011). ASD is viewed as being a spectrum disorder, with significant phenotypic and genotypic heterogeneity (Abrahams & 
Geschwind, 2008). It may be part of a Broader Autism Phenotype (BAP) (Sucksmith, 2012), or explained by a sub threshold autism 
spectrum model which encompasses those on the spectrum with a diagnosis and those who are sub threshold acknowledging the 
different severity of presentation (Dell’Osso et al., 2016). It is hypothesised that individuals with autistic traits have a higher 
vulnerability towards psychopathology and risk of comorbid mental health problems (Dell’Osso, Carpita et al., 2019; Dell’Osso, 
Lorenzi, & Carpita, 2019). Recognition of ASD is key to successful clinical intervention and service provision (National Audit Office, 
2009). It is still common for individuals with elevated levels of autistic traits to remain unrecognised in adulthood. Therefore, the 
assessment of ASD in high-risk adult populations, e.g. in the criminal justice and mental health services requires the further devel-
opment of screening and diagnostic assessments within these services (Underwood et al., 2016). 
The exact prevalence of ASD within prisons is currently unknown (Robinson et al., 2012). As previously highlighted by (Chaplin & 
McCarthy, 2014) in the United Kingdom, screening for ASD is not part of the usual prison process. This lack of screening for ASD 
presents a significant problem across the whole of the criminal justice system (Cooper & Allely, 2017; Myers, 2004). There were 77,738 
prisoners in the United Kingdom in April 2021 (Ministry of Justice, & Her Majesty’s Prison & Probation Service, 2021). Estimates of 
autistic prisoners range from 1 to 4.4 % (Fazel & Seewald, 2012; Robinson et al., 2012). It is important to consider that the rates of ASD 
in prison may vary depending on the type of prisoners (remand or sentenced) or by level of risk (Underwood, Forrester, Chaplin, & 
McCarthy, 2013). Although research into prisoners with autism has grown, there is little specific to those with elevated levels of 
autistic traits. Often this group will present has high level of need, but not be eligible for current services and support. Many will only 
be recognised initially when they come to the attention of services due to psychiatric conditions or at risk of suicide and self-harm 
(Dell’Osso, Carpita et al., 2019). Where often crisis may be avoided with appropriate support. 
2. Present study 
Currently there is a lack of agreement as to suitable screening and assessment tools in prisons to identify individuals with autistic 
traits for a number of reasons (Robinson et al., 2012). These include time constraints and validity of measures in offender populations. 
Diagnosis of ASD in prison can be difficult as it relies on corroborating evidence which is often not available, as many will have little or 
no contact with families (Underwood et al., 2016). By introducing screening and diagnostic assessment in a prison setting as part of the 
present study, several potential benefits were noted. Screening could assist in making reasonable adjustments, so autistic prisoners who 
have had previous difficulty can engage in offender treatment programs. This is important as being able to engage can influence 
decisions on parole or release. Adults with ASD are well recognised to be more vulnerable to mental disorders, with rates of between 
16–35 % being reported (Royal College of Psychiatrists, 2014, 2020) Studies have found a history of mental health comorbidities to be 
common in individuals with ASD who have engaged in offending behaviour (Allen et al., 2008; Im, 2016a, 2016b; Newman & 
Ghaziuddin, 2008; Sabet, Underwood, Chaplin, Hayward, & McCarthy, 2015) including schizophrenia and neurodevelopmental 
disorders such as attention-deficit/hyperactivity disorder (ADHD). This paper therefore focuses on the issue of these vulnerabilities for 
autistic prisoners by describing our approach to screening in a prison setting and so allowing a comparison of the mental health, 
substance and alcohol misuse, self-harm and suicide behaviours and offending characteristics of three groups of prisoners in a local 
London prison, i.e.:  
1. prisoners who have screened positive on the AQ-20/AQ-10 with elevated autistic traits  
2. prisoners meeting the diagnostic threshold for the ADOS  
3. neurotypical prisoners who have not screened positive for intellectual disability (ID) or attention-deficit/hyperactivity disorder 
(ADHD)1 
1 Those screening positive for ID and ADHD were excluded due to high rates of comorbidity. 
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The study took place in a male London prison (category C). The official capacity of the prison was 798. The study used a purposive 
sampling strategy and was able to approach 378 prisoners over the four wings and new prisoners arriving in past 4 weeks. Of these 378 
prisoners, 240 consented to screening and subsequent diagnostic assessment. There were complete datasets for suicide and self-harm, 
mental disorder and substance use for 37 prisoners, of the 46 screened with elevated levels of autistic traits. A control group of 69 
neurotypical prisoners with a complete mental health dataset were used for comparison. 
Prisoners were only excluded from the study if they lacked capacity to consent or could not understand or express themselves in 
English. Participants included new arrivals to the prison and referrals by prison healthcare staff, education staff or self-referral. 
3.2. Measures 
The study collected self-reported data on a range of demographic data as well as rates of previous offending from the prison case 
note records and used the following measures to define the groups of interest, using recommended predetermined cut off scores and 
guidance. The 20-item Autism Quotient was used (Brugha et al., 2009, 2011). A score greater than or equal to 10 was used to indicate 
the presence of clinically significant autistic traits (Wilson et al., 2014), with 39 prisoners screening positive with significant autistic 
traits according to the AQ-20 (total score ⩾10). Of these 32 underwent further assessment. Seven participants were lost to follow-up 
and 21 did not meet the diagnostic threshold. 
The AQ-10 was used on the remaining prisoners to be screened following its inclusion and recommendation from the NICE 
guidelines which were introduced during the time of the study (Wilson et al., 2014). The change was also made as part of the project’s 
commitment to sustainability of future screening reflecting best practice following the end of the study. A score greater than or equal to 
6 was used to indicate the presence of clinically significant autistic traits. A further seven screened positive, before the end of the study. 
Diagnostic assessment for ASD was carried out using the Autism Diagnostic Observation Schedule (ADOS) (Lord et al., 1989) and the 
Autism Diagnostic Interview (ADI-R) (Lord, Rutter, & Le Couteur, 1994). However only two informants were available to complete the 
ADI-R so limiting the use of this data but illustrated the challenge of identifying informants who can provided a developmental history 
for those in prison. The standardised ADOS assessment was adapted to meet prison security requirements (Underwood et al., 2016). 
Evidence from case notes of any previous or current clinical interview was also sought to see if there was an existing ASD diagnosis or 
evidence to support a positive ADOS and ADI-R assessment. 
There is little information of reliability and validity in prison populations of the autism related measures used. In general pop-
ulations the AQ-10 has reported rates of sensitivity and specificity were reported at 0.88 and 0.91 respectively (Allison, Auyeung, & 
Baron-Cohen, 2012). Although more recent research has questioned its internal reliability (Bertrams, 2021). Both the ADI-R and ADOS 
had similar correct classification scores for autism of 0.85 and 0.80, with the ADOS score also dependent on module and algorithm used 
(Falkmer, Anderson, Falkmer, & Horlin, 2013) 
The AQ-20, AQ-10 and MINI were completed by a trained researcher interviewing the prisoner. The ADOS and ADI-R were 
administered by researchers and mental health professionals trained in their use. Researchers were blinded to previous assessment 
scores. 
Participants from both groups were assessed for suicidality, self-harm, mental disorder, alcohol misuse/dependency and substance 
misuse/dependency using the Mini International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998) to generate ICD-10 (10th 
revision of the International Statistical Classification of Diseases and Related Health Problems) diagnoses (World Health Organization, 
1992). 
ADHD was screened for using the Adult ADHD Self-Report Scale (ASRS-v1.1) (Adler et al., 2006) and the presence of ID using the 
Learning Disability Screening Questionnaire (LDSQ) (McKenzie, Michie, Murray, & Hales, 2012). Given the transient nature of the 
prison population, data was not available for all prisoners for suicidality, self-harm, mental health problems and alcohol and substance 
misuse/dependency. The numbers screened for each of these are listed in the results and tables and represent those with complete data 
sets in the areas listed. The comparison groups represent neurotypical prisoners, that is all prisoners who did not screen with elevated 
traits and positive for a neurodevelopmental conditions. 
3.3. Analysis 
Chi-square likelihood ratios were used to analyse categorical and continuous data, respectively, using SPSS v 22. This method is 
recommended for small samples and where any of the cell counts may be under five (Özdemir & Eyduran, 2005). The prisoners with 
elevated autistic traits as measured using the AQ were compared with those prisoners who did not meet the threshold on screening for a 
neurodevelopmental disorder. We also included those meeting the diagnostic threshold using the ADOS as a separate group in the 
analysis with the aim to explore if their risks for comorbid mental disorder and self-harm behaviour differed or not to those with 
elevated autistic traits using the AQ. 
4. Results 
In total, of the 240 prisoners, 46 participants screened positive for autistic traits. Of these 12 had a positive ADOS score. Of the 12 
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only two were known to the prison as having ASD, meaning that 83.3 % cases meeting the diagnostic threshold were not identified. 
4.1. Demographic 
In terms of age distribution, there is little difference between prisoners in the three groups. In terms of ethnicity, white prisoners 
were significantly more likely to screen positive for autistic traits and made up 91.7 % of the ADOS +ve group see Table 1. 
4.2. Risk for self-harm and/or suicide behaviours 
Prisoners screening positive with autistic traits were significantly more likely than neurotypical prisoners to report having thought 
about self-harm or suicide in the month prior to the research assessment. They were also significantly more likely to report having 
attempted suicide during their lifetime compared to neurotypical peers at a rate of 64.9 % compared to 11.6 % for the neurotypical 
prisoners and 45.5 % in ADOS +ve prisoners (see Table 2). 
4.3. Mental illness and personality disorder comorbidities 
Table 3 shows that prisoners screening positive with autistic traits were more likely to have comorbid major depressive episode, 
generalised anxiety disorder, social phobia and anti-social personality disorder. They also had higher rates of all other comorbid 
mental disorders such as psychosis but the numbers were too small to show any significant difference. The neurotypical prisoners and 
those with elevated levels of autistic traits had much higher rates of antisocial personality disorder compared to the ADOS +ve 
prisoners. The ADOS +ve group significantly more likely to be diagnosed with anxiety related disorders namely social phobia and 
obsessive-compulsive disorder. 
4.4. Risk for history of alcohol and drug use 
There was no significant difference between the neurotypical prisoners and those with autistic traits with regards to their history of 
alcohol and drug abuse or dependency, although autistic prisoners were more likely to be dependent on alcohol, whereas neurotypical 
prisoners more likely to have a drug dependency see Table 4. None of the ADOS +ve group reported alcohol abuse and rates of de-
pendency were much lower than the two other groups. 
5. Discussion 
We have shown in this sample, of prisoners screening positive with autistic traits were significantly more likely than neurotypical 
prisoners to have thought about self-harm or suicide and significantly more likely to report to have attempted suicide during their 
lifetime when compared to their neurotypical peers and ADOS +ve group. Prisoners with elevated levels of autistic traits were much 
more at risk to a of comorbid mental disorders. In addition, those prisoners with autistic traits had much higher rates of antisocial 
personality disorder. Many of the findings concur with previous research, for example we know those with traits of neuro-
developmental disorders in prison appear more vulnerable to a wider range of mental disorder, self-harm and suicidality (McCarthy 
et al., 2019). This paper examined a subset with autistic traits and has found the same for this group of prisoners. There is the pos-
sibility that the presence of other comorbid mental disorder such mood or psychotic symptoms may have led to elevated autistic traits 
being identified using the AQ. However, a standardised psychiatric interview was used during the study to elicit the symptoms of 
specific psychiatric disorders and the items of the AQ focus on the core impairments of an autism spectrum disorder. This requires 
further exploration but there is an evidence base supporting the increased risk of those with autism spectrum disorder for comorbid 
mental disorder (Royal College of Psychiatrists, 2014, 2020). 
Table 1 
Age and Ethnicity between prisoners with no Neurodevelopmental difficulties (ND) traits and those with autistic traits.   
No ND 
n = (153) 
#n = (151) 
+ve autistic traits 
n = (46) 
X2 
Sig * P<.05 
Sig ** P<.00 
ADOS +ve 
n = (12) 
X2 
Sig * P<.05 
Sig ** P<.00 
Age in 10 yr intervals 
20–29 60, 39.2 % 22, 47.8 % X2 = (n = 199) 5.53, P = .137 5, 41.7 % X2 = (n = 165) 1.06, p = .787 
30–39 41, 26.8 % 10, 21.7 %  2, 16.7 %  
40–49 35, 22.9 % 13, 28.3 %  4, 33.3 %  
50+ 17, 11.1 % 1, 2.2 %  1, 8.3 %  
Ethnicity 
N = 204 
White 65, 43 % 37, 80.4 % X2 = (n = 197) 16.48, P <.001** 11, 91.7 % X22 = (N = 163) 14.73, p<.001** 
Black 65, 43 % 7, 15.2 %  0, 0%  
Asian 21, 13.9 % 2, 4.3 %  1, 8.3 %   
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5.1. Implications for practice 
5.1.1. Risk for self-harm and/or suicide behaviours 
There is relatively little research evidence or knowledge on suicide in adults with ASD although there are case reports that may offer 
some insights (Richa, Fahed, Khoury, & Mishara, 2014). Also, there is limited evidence regarding suicide relating to ASD within the 
prison population. Estimates of suicidality in general for individuals with ASD range from 10.7 to 50% (Segers & Rawana, 2014). This 
study showed that those prisoners with autistic traits had higher rates of lifetime attempted suicide up to 65 % indicating that this 
group is a very high-risk population coming into prison, who will require a more intensive and involved clinical input. A study of 542 
prisoners in England, which employed a prediction model for self-harm showed the strongest risk factors were previous self-harm and 
current suicidal ideation with our findings indicating those prisoners with autistic traits falling into a group with high rates of previous 
self-harm behaviour. A recent rapid evidence review of self-harm by adult men in prison, published by Her Majesty’s Prison and 
Probation Service (Pope, 2018). This review failed to identify or consider ASD as a possible risk factor or that the group were at higher 
risk. However, the evidence from the findings of this study indicate that the elevated levels of autistic traits are possibly a significant 
risk factor for self-harm behaviour within a prison setting. 
Table 2 
Current suicide related behaviours and other self-harm between prisoners with no ND traits and those with autistic traits.  
Suicide related behaviours & self- 
harm 
No ND 
(n = 69) 
+ve autistic traits 
n = (n = 36,) #(n = 37) 
X2 
Sig * P<.05 
Sig ** P<.00 
ADOS +ve 
n = (11) 
X2 
Sig * P<.05 
Sig ** P<.00 
Thoughts about self-harm 3, 21.4 % 11, 30.6 % X2  = (n = 105) 13.46, P 
<.001** 
3, 27.3 % X2  = (n = 80) 2.30, P = .129 
Actual self-harm# 1, 12.5 % 7, 18.9 % X2  = (n = 106) 10.38, P 
<.001** 
2, 18.2 % X2  = (n = 80) 3.42, P = .084 
Thoughts about suicide 3, 4.3 % 11, 30.6 % X2  = (n = 105) 13.46, P 
<.001** 
3, 27.3 % X2  = (n = 80) 2.69, P = .101 
Attempted suicide 0, 0% 1, 2.8 % X2  = (n = 105) 2.16, P = .142 0,0% X2  = (n = 80) 10.63, 
P = .428 
Suicide attempts #(Lifetime) 8, 11.6 % 24, 64.9 % X2  = (n = 106) 32.36, P 
<.001** 
5, 45.5 % X2  = (n = 80) 2.96, P = .086  
Table 3 




n = 69 
+ve autistic traits 
n = 37 
X2 
Sig * P<.05 




Sig * P<.05 
Sig ** P<.00 
Psychosis 1, 1.4 % 3, 8.1 % X2  = (n = 106) 2.79, P = .095 0, 0% X2  = (n = 80) .298, P = .585 
Affective disorders      
Depression 2, 15.4 % 11, 29.7 % X2 = (n = 106) 15.76, P <.001** 2, 18.2 % X2  = (n = 80) 3.23, P = .072 
Major depression with 
psychotic features 
2, 2.9 % 4, 10.8 % X2 = (n = 106) 2.66, P <.037* 0, 0% X2  = (n = 80) .600, P = .439 
Mania or Hypomania 3,4.3 % 8, 21.6 % X2 = (n = 106) 7.34, P = .007* 1, 9.1 % X2  = (n = 80) .380, P = .538 
GAD 3, 4.3 % 10, 27 % X2 = (n = 106) 11.03, P <.001** 2, 18.2 % X2  = (n = 80) 2.30, P = .130 
Social Phobia 3, 4.3 % 15, 40.5 % X2 = (n = 106) 21.94, P <.001** 3, 27.3 % X2  = (n = 80) 5.05, P <.025* 
Obsessive compulsive disorder 4, 5.8 % 8, 21.8 % X2 = (n = 106) 5.69, P <.017* 3, 27.3 % X2  = (n = 80) 4.04, P = .045* 
Post-traumatic stress disorder (PTSD) 4, 5.8 % 6, 16.2 % X2  = (n = 106) 2.90, P = .089 1, 9.1 % X2  = (n = 80) .159, P = .690 
Antisocial Personality Disorder 16, 23.2 % 24, 64.9 % X2  = (n = 106) 17.80, P<.001** 2, 18.2 % X2  = (n = 80) 1.42 P = .706  
Table 4 
Comparison of prisoner comorbidity and likelihood of drug/alcohol use - no ND and autistic traits.   
No ND 
(n = 69) 
+ve autistic traits 
n = (37) 
X2 
Sig * P<.05 
Sig ** P<.00 
ASD 
n = (11) 
X2 
Sig * P<.05 
Sig ** P<.00 
Alcohol dependency 7, 10.1 % 8, 21.6 % X2  = (n = 106) 2.50, P = .114 1, 9.1 % X2  = (n = 80) 0.12 P = .913 
Alcohol Abuse 2, 2.9 % 0,0% X2  = (n = 106) 1.74, P = .187 0, 0% X2  = (n = 80) .600 P = .439 
Drug Dependency 12, 17.4 % 12, 32.4 % X2  = (n = 106) 3.01, P = .083 2, 18.2 % X2  = (n = 80) 0.04, P = .949 
Drug Abuse 4, 5.8 % 1, 2.7 % X2  = (n = 106) 056, P = .454 0, 0% X2  = (n = 80) 1.21 P = .270  
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5.1.2. Comorbid mental health disorder 
Much of the research on mental health needs in people with ASD comes from children and younger adults, with mood and anxiety 
disorders reported at higher rates in a number of studies (Bruggink, Huisman, Vuijk, Kraaij, & Garnefski, 2016) but adult studies also 
confirm high rates of mental health difficulties (Moss, Howlin, Savage, Bolton, & Rutter, 2015). However, there is little information 
from prison populations although high rates of comorbid mental health disorders in those with neurodevelopmental disorders were 
reported from a study at HMP Brixton (Chaplin et al., 2017; McCarthy et al., 2019; Underwood et al., 2013, 2016). This current study 
found those with elevated levels of autistic traits were significantly more likely to have a diagnosis of depression, anxiety and per-
sonality disorders. These findings clearly indicate that there is a need not only identify whether a prisoner has ASD or autistic traits (if it 
is not already known) but whether that individual also has any comorbid mental health disorders as this psychological complexity may 
potentially have an adverse impact on their rehabilitation and reintegration (Robertson & McGillivray, 2015). In addition, mental 
disorders in individuals with autistic traits (such as anxiety and depression) can further exacerbate problems or difficulties they are 
facing within a prison setting. Again this highlights the need for more defined and involved clinical input for this group within the 
prison. 
5.2. Limitations 
The study had a number of limitations. These included it reports on only one prison. There is also a lack of psychometric data on the 
use of the AQ-20 and AQ-10, in prison populations. The study found that although the AQ did have the ability to discriminate ASD 
patients from patients without ASD, and the social skills, communication and attention switching subscales were identified as being the 
most sensitive. Another important issue to consider is that the use of the AQ may be limited only to individuals who possess sufficient 
literacy skills. A number of studies have found “extremely poor literacy skills” in prisoners (Creese, 2016). There is a need for a 
modified version of the AQ which could be conducted using a semi-structured interview approach within forensic settings (Murphy, 
2011). Clearly, there is a need for more research looking at the validity of screening methods in prison populations and also the rates of 
false negatives (Silva, Gough, & Weeks, 2015). In addition, ASD screening tools have been developed (and therefore normed) based on 
the male phenotype which questions the validity of these tools for autistic females. Further studies are required on how best to screen 
for autism spectrum disorder or autistic traits in female prisoners. 
The change of screening tool was not ideal but was as a response to National Policy and designed to ensure the prison had access to 
the latest tools as education and advice to the local prison healthcare was integral to the study as was sustainability of screening within 
the prison. Finally the movement of prisoners within and to other prisons was often responsible for incomplete data for MINI following 
screening for autistic traits. 
5.3. Future research directions 
5.3.1. Improving Health Outcomes for Prisoners with ASD including those with elevated autistic traits 
The findings from the present study clearly highlight the importance of further research to explore both the prevalence as well as 
the characteristics of non-suicidal self-injury (NSSI) in prisoners with autistic traits as well as suicidal behaviour. Maddox has also 
suggested the need for longitudinal studies to examine the potential pathways to NSSI and the associated consequences or outcomes 
(Maddox, Trubanova, & White, 2017) in individuals with ASD within forensic settings. 
In order to further improve healthcare within the prison there needs to be increased recognition and understanding of ASD and the 
broader autistic phenotype, with autistic traits. There also needs to be increased understanding regarding the detection (and appro-
priate intervention) of comorbid mental health or behavioural problems in this group. Training for prison staff should include these 
areas and the training should also be tailored specifically to each of the types of prison staff (Underwood et al., 2016). 
5.3.2. Experiences of individuals with ASD within the prison environment 
There is a need for additional research exploring the experiences of individuals with autistic traits or broader autistic phenotype in 
the prison environment. This research would help inform the development and availability of effective support and protective systems 
for this group of prisoners. Another important step forward could be the development of specific pathways of care for those in the 
prison with a diagnosis of ASD (Woodbury-Smith & Dein, 2014) similar to what currently exists for individuals with personality 
disorders who become involved in the criminal justice system. 
6. Conclusion 
Prisoners with elevated levels of autistic traits did appear more vulnerable to reporting self-harm, suicidal thoughts and were more 
vulnerable to a range of mental disorders than neurotypical prisoners. This strengthens the case for increased awareness and access to 
screening and subsequent diagnosis which currently prisons are currently not set up for. There are questions around the validity and 
usefulness of current screening tools for ASD in forensic populations. Finally, we need more evidence on the experience of autistic 
prisoners to inform how pathways should work to improve health outcomes for this group of prisoners. 
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